Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
129.56
-1.32 (-1.01%)
Nov 18, 2026, 3:00 PM CST

SHA:600436 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,2261,2561,4881,1592,4967,097
Short-Term Investments
-1,2923,5209,0146,202-
Trading Asset Securities
-----8.8
Cash & Short-Term Investments
2,2262,5485,00810,1738,6987,106
Cash Growth
65.23%-49.12%-50.78%16.95%22.42%37.48%
Accounts Receivable
948.44830.91894.431,021859.49673.3
Other Receivables
75.5267.963.9565.15107.94134.95
Receivables
1,024898.81958.381,086967.43808.25
Inventory
5,6966,6794,9673,3792,6282,438
Prepaid Expenses
-97.2812.8214.054.5520.68
Other Current Assets
4,534445.83382.92447.9406.61261.36
Total Current Assets
13,48010,66911,32915,10012,70510,633
Property, Plant & Equipment
2,1791,9371,508614.62465.62400.14
Long-Term Investments
1,3111,364870.45631.98673.7799.87
Other Intangible Assets
341.48267.49273.1291.09319.37220.96
Long-Term Deferred Tax Assets
132.26115.43155.5187.31167.26166.98
Long-Term Deferred Charges
24.9530.5434.0529.9937.6544.19
Other Long-Term Assets
246.083,1773,370225.4235.41255.59
Total Assets
17,71517,56017,54017,08014,60412,521

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
548.5547.81480.01667.92464.9386.99
Accrued Expenses
152.54275.91485.41685.98345.39342.14
Short-Term Debt
819.07838.13892.79989.93970.96775.79
Current Portion of Long-Term Debt
42.427.676.991.87--
Current Portion of Leases
-32.6235.8131.8629.2122.75
Current Income Taxes Payable
92.245.0659.07142.6572.93108.96
Current Unearned Revenue
168.43269.18270.81237.1468.57326.56
Other Current Liabilities
917.99148.2142.92125.8158.22173.9
Total Current Liabilities
2,7412,1252,3742,8832,5102,137
Long-Term Debt
48.4856.0858.1535.44--
Long-Term Leases
111.97127.66154.58107.29108.886.67
Long-Term Unearned Revenue
25.8126.2626.6817.6717.0120.24
Pension & Post-Retirement Benefits
52.5353.1753.2835.0434.2932.23
Long-Term Deferred Tax Liabilities
47.9752.980.3330.0261.0974.52
Other Long-Term Liabilities
26.6431.2334.151.3548.5432.88
Total Liabilities
3,0552,4722,7013,1602,7802,384

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
603.32603.32603.32603.32603.32603.32
Additional Paid-In Capital
1,0951,0951,0951,0951,0941,086
Retained Earnings
12,40412,70912,49711,6029,5597,816
Comprehensive Income & Other
48.6132.1876.9276.674.41200.05
Total Common Equity
14,15114,53914,27213,37611,3309,705
Minority Interest
509.06548.58567.01544.17493.97432.07
Shareholders' Equity
14,66015,08814,83913,92011,82410,138
Total Liabilities & Equity
17,71517,56017,54017,08014,60412,521

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,0221,0621,1481,1661,109885.21
Net Cash (Debt)
1,2041,4863,8599,0077,5896,220
Net Cash Growth
317.86%-61.50%-57.15%18.67%22.01%39.78%
Net Cash Per Share
1.992.466.3914.9412.5910.31
Filing Date Shares Outstanding
603.32603.32603.32603.32603.32603.32
Total Common Shares Outstanding
603.32603.32603.32603.32603.32603.32
Working Capital
10,7398,5448,95512,21710,1958,496
Book Value Per Share
23.4624.1023.6622.1718.7816.09
Tangible Book Value
13,80914,27213,99913,08511,0119,484
Tangible Book Value Per Share
22.8923.6623.2021.6918.2515.72
Buildings
-624.021,095400.13331.45332.55
Machinery
-408.37368.02345.33324.4300.25
Construction In Progress
-1,248314.85157.1960.7814.94